These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 20405138

  • 1. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.
    Zhang K, Zeng Y, Song C, Fu Y, Wan Q.
    J Neurol; 2010 Sep; 257(9):1486-91. PubMed ID: 20405138
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [Abstract] [Full Text] [Related]

  • 3. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT, Longo K, Manfredi M, Lucetti C, Cossu G, Petrone A, Marconi R, Sensi M, Epifanio A, Eleopra R, Marchese R, Scaravilli T, Morgante L, Abbruzzese G, Bonuccelli U, Donati E, Pivonello R, Colao A, Barone P.
    Mov Disord; 2008 Jan 30; 23(2):190-4. PubMed ID: 18044703
    [Abstract] [Full Text] [Related]

  • 4. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA, Kim BJ, Lee WY.
    Mov Disord; 2002 Nov 30; 17(6):1242-7. PubMed ID: 12465063
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia.
    Pellecchia MT, Salvatore E, Pivonello R, Faggiano A, Barone P, De Michele G, Colao AM, Filla A.
    Neurol Sci; 2001 Feb 30; 22(1):79-80. PubMed ID: 11487211
    [Abstract] [Full Text] [Related]

  • 6. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR, Watson L, Mathias CJ.
    Lancet; 1997 Jun 28; 349(9069):1877-81. PubMed ID: 9217760
    [Abstract] [Full Text] [Related]

  • 7. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test.
    Pellecchia MT, Longo K, Pivonello R, Lucetti C, Marchese R, Spampani A, Manfredi M, Epifanio A, Sensi M, Scaravilli T, Bracco F, Eleopra R, Morgante L, Donati E, Marconi R, Abbruzzese G, Bonuccelli U, Zappia M, Colao A, Barone P.
    Ann Neurol; 2006 Nov 28; 60(5):611-615. PubMed ID: 16958123
    [Abstract] [Full Text] [Related]

  • 8. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM.
    J Neurol; 2000 Nov 28; 247(11):853-6. PubMed ID: 11151417
    [Abstract] [Full Text] [Related]

  • 9. Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study.
    Bonnard C, Wirth T, Gebus O, Fahrer P, Montaut S, Robelin L, Tuzin N, Tranchant C, Anheim M.
    J Neurol; 2020 Mar 28; 267(3):855-859. PubMed ID: 32034477
    [Abstract] [Full Text] [Related]

  • 10. Prospective study of relevance of 123I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson's disease and multiple system atrophy.
    Alves Do Rego C, Namer IJ, Marcel C, Lefebvre F, Lagha-Boukbiza O, Renaud M, Tranchant C, Anheim M.
    J Neurol; 2018 Sep 28; 265(9):2033-2039. PubMed ID: 29956027
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.
    Pellecchia MT, Pivonello R, Colao A, Barone P.
    Clin Med Res; 2006 Dec 28; 4(4):322-5. PubMed ID: 17210980
    [Abstract] [Full Text] [Related]

  • 12. Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.
    Krismer F, Seppi K, Göbel G, Steiger R, Zucal I, Boesch S, Gizewski ER, Wenning GK, Poewe W, Scherfler C.
    Mov Disord; 2019 Jul 28; 34(7):1041-1048. PubMed ID: 30919495
    [Abstract] [Full Text] [Related]

  • 13. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
    Mangesius S, Mariotto S, Ferrari S, Pereverzyev S, Lerchner H, Haider L, Gizewski ER, Wenning G, Seppi K, Reindl M, Poewe W.
    Parkinsonism Relat Disord; 2020 Aug 28; 77():57-63. PubMed ID: 32622301
    [Abstract] [Full Text] [Related]

  • 14. Combined simultaneous arginine clonidine stimulation test: Timing of peak growth hormone (GH) concentration and correlation with clinical indices of GH status.
    Bhat N, Dulmovits E, Lane A, Messina C, Wilson T.
    Growth Horm IGF Res; 2018 Jun 28; 40():28-31. PubMed ID: 29702359
    [Abstract] [Full Text] [Related]

  • 15. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ, Lee WY, Yoon WT, Kim BJ, Lee GH.
    Mov Disord; 2009 Aug 15; 24(11):1650-5. PubMed ID: 19514077
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC, Vestergaard P, Jakobsen PE, Falhof J, Laurberg P.
    J Clin Endocrinol Metab; 2000 Apr 15; 85(4):1467-72. PubMed ID: 10770183
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
    Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML.
    J Clin Endocrinol Metab; 2002 May 15; 87(5):2067-79. PubMed ID: 11994342
    [Abstract] [Full Text] [Related]

  • 18. The putaminal abnormalities on 3.0T magnetic resonance imaging: can they separate parkinsonism-predominant multiple system atrophy from Parkinson's disease?
    Feng JY, Huang B, Yang WQ, Zhang YH, Wang LM, Wang LJ, Zhong XL.
    Acta Radiol; 2015 Mar 15; 56(3):322-8. PubMed ID: 24619850
    [Abstract] [Full Text] [Related]

  • 19. Diagnosing Growth Hormone Deficiency: Can a Combined Arginine and Clonidine Stimulation Test Replace 2 Separate Tests?
    Oron T, Krieger A, Yakobovich-Gavan M, Tenenbaum A, Diamant R, Phillip M, Lazar L.
    Endocr Pract; 2022 Jan 15; 28(1):36-43. PubMed ID: 34418530
    [Abstract] [Full Text] [Related]

  • 20. Arginine test is not reliable for diagnosing cerebellar multiple system atrophy.
    Gardner RC, Schmahmann JD.
    Ann Neurol; 2010 Mar 15; 67(3):404-8. PubMed ID: 20373353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.